Effectiveness of Tocilizumab in Patients Hospitalized With COVID-19: A Follow-up of the CORIMUNO-TOCI-1 Randomized Clinical Trial

This follow-up study of the CORIMUNO-TOCI-1 randomized clinical trial examines the association between survival and C-reactive protein levels in patients hospitalized with COVID-19 who were treated with tocilizumab.

Uloženo v:
Podrobná bibliografie
Vydáno v:JAMA Intern Med
Hlavní autoři: Mariette, Xavier, Hermine, Olivier, Tharaux, Pierre-Louis, Resche-Rigon, Matthieu, Steg, Philippe Gabriel, Porcher, Raphaël, Ravaud, Philippe
Médium: Artigo
Jazyk:Inglês
Vydáno: American Medical Association 2021
Témata:
Research Letter
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8145157/
https://ncbi.nlm.nih.gov/pubmed/34028504
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamainternmed.2021.2209
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky